IM
Healthcare & Life Sciences
ImmunAbs
Seoul, South Koreawww.immunabs.com/
ImmunAbs is a Healthcare & Life Sciences startup based in Seoul, South Korea, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2017
Founded
1
Investors
About ImmunAbs
ImmunAbs is a startup founded in 2017 based in Seoul, South Korea. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ImmunAbs develops antibody therapeutics targeting autoimmune diseases involving complement regulatory system abnormalities, diabetic retinopathy, and diabetes, utilizing proprietary antibody screening and engineering technologies such as phage display and single B cell cloning.
Explore ImmunAbs's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.